Tien Liang BioTech Co., Ltd. (TPEX:4127)

Tien Liang BioTech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	167.11	122.31	130.67	142.22	107.84	118.47
Short-Term Investments	30	30	-	-	-	-
Cash & Short-Term Investments	197.11	152.31	130.67	142.22	107.84	118.47
Cash Growth	3.17%	16.56%	-8.12%	31.87%	-8.97%	2.81%
Accounts Receivable	46.59	47.02	40.89	75.04	97.05	97.84
Other Receivables	0.17	0.22	0.1	0.01	0.01	-
Receivables	46.76	47.24	40.98	75.05	97.07	97.84
Inventory	55.25	67.04	58.49	75.8	94.97	60.95
Prepaid Expenses	6.39	7.1	8.82	11.15	22.48	13.4
Other Current Assets	10.34	11.42	7.58	4.83	3.92	4.22
Total Current Assets	315.84	285.11	246.54	309.04	326.27	294.89
Property, Plant & Equipment	338.5	335.55	324.07	334.03	339.2	349.48
Long-Term Investments	-	536.23	296.65	-	-	-
Other Intangible Assets	0.31	0.4	0.44	0.51	0.24	0.62
Long-Term Deferred Tax Assets	3.55	3.65	5.36	5.6	5.89	5.79
Other Long-Term Assets	565.15	22.29	15.62	4.86	4.82	4.58
Total Assets	1,223	1,183	888.68	654.04	676.43	655.35

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	58.38	56.51	32.9	25.9	26.05	46.41
Accrued Expenses	38.87	38.24	28.33	29.55	40.46	28.61
Short-Term Debt	598	598	335	70	100	130.5
Current Portion of Leases	-	-	0.38	0.5	0.52	0.78
Current Income Taxes Payable	-	-	-	0.73	-	-
Other Current Liabilities	8.76	16.14	10.78	18.17	18.49	17.86
Total Current Liabilities	704.01	708.89	407.38	144.85	185.51	224.16
Long-Term Leases	-	-	-	0.38	0.88	1.4
Pension & Post-Retirement Benefits	-	-	-	15.8	14.52	15.69
Long-Term Deferred Tax Liabilities	0.09	0.3	3.38	0.03	0.4	0.05
Total Liabilities	704.1	709.19	410.76	161.05	201.3	241.3

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	457.6	457.6	457.6	457.6	457.6	457.6
Retained Earnings	71.61	23.24	32.93	35.38	17.53	-43.55
Comprehensive Income & Other	-9.96	-6.8	-12.6	-	-	-
Shareholders' Equity	519.25	474.04	477.92	492.98	475.13	414.05
Total Liabilities & Equity	1,223	1,183	888.68	654.04	676.43	655.35

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	598	598	335.38	70.88	101.4	132.67
Net Cash (Debt)	-400.9	-445.69	-204.71	71.34	6.44	-14.21
Net Cash Growth	-	-	-	1007.04%	-	-
Net Cash Per Share	-8.76	-9.74	-4.47	1.56	0.14	-0.31
Filing Date Shares Outstanding	45.76	45.76	45.76	45.76	45.76	45.76
Total Common Shares Outstanding	45.76	45.76	45.76	45.76	45.76	45.76
Working Capital	-388.17	-423.77	-160.84	164.19	140.76	70.73
Book Value Per Share	11.35	10.36	10.44	10.77	10.38	9.05
Tangible Book Value	518.94	473.64	477.48	492.47	474.88	413.43
Tangible Book Value Per Share	11.34	10.35	10.43	10.76	10.38	9.03
Land	144.74	144.74	144.74	144.74	144.74	144.74
Buildings	308.93	311.75	298.32	298.05	297.83	297.83
Machinery	29.81	89.04	87.73	103.86	99.44	99.39
Leasehold Improvements	-	-	-	-	-	0.27

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 6, 2026

Data Sources Report a data error